Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
DMSXL mice
Myostatin
Antisense oligonucleotides
CONGENITAL MYATHENIC SYNDROME
Dilated cardiomyopathy
CRISPRi
Muscle
RNA biology
CRISPR/Cas9
RNA splicing
ACETYLCHOLINESTERASE
Autophagy
KNOCKOUT MICE
Transgenic mouse model
Male
Oligodendrocytes
Endurance training
Astrocytes
In vivo
PCR
RNA interference
Long read sequencing
Thérapie génique
Gene therapy
Trinucleotide Repeat Expansion
Neuron
Heart failure
Humans
Skeletal muscle
Exercice
CMS
Myotonic dystrophy mouse models
Acetylcholinesterase deficiency
Hypoxia
PacBio
GABA
Cardiac muscle
Myotonic Dystrophy
Myotonic Dystrophy Type 1
Glial cells
CTG repeats
Dynamin 2
Myelin
Duchenne muscular dystrophy
Glucocorticoid-receptor
Heart
Exercise
Alternative splicing
Astrocyte
Knockout
Glucocorticoids
Fibrosis
Brain dysfunction
Intermediate filament
Mouse models
Dystrophie Myotonique
BIOLOGIE MOLECULAIRE
Acute coronary syndrome
Transcriptomics
Myotonic Dystrophy type 1
Maximal force
Mice
Cell culture model
AAV
Animals
Gene editing
Aging
Expression
Mouse model
ARN
MBNL
Therapy
Gene Therapy
CTG repeat instability
Dystrophin
Centronuclear myopathy
Dystrophie myotonique
Glutamate
Acetylcholinesterase knockout mouse
Quantitative microdialysis
Cell penetrating peptide
Brain
Diaphragm
Myotonic dystrophy type 1
Muscular dystrophy
Cytoskeleton
DMPK
Myotonic dystrophy
Desmin
GSK3
Antisense oligonucleotide
Trinucleotide repeat expansion
Central nervous system
Transgenic mouse
Oligodendrocyte
Cell model
Genotype phenotype correlation
DM1
Motoneuron
CTG repeat contractions